Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Capital Expenditures (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Capital Expenditures for 7 consecutive years, with $159000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 31.17% to $159000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $314000.0 through Dec 2025, up 12.95% year-over-year, with the annual reading at $314000.0 for FY2025, 12.95% up from the prior year.
  • Capital Expenditures for Q4 2025 was $159000.0 at Fulcrum Therapeutics, up from $90000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $1.3 million in Q2 2022, with the low at -$1.8 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $64611.1, with a median of $84500.0 recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 822.02% in 2021, while the deepest fall reached 345.13% in 2021.
  • Over 5 years, Capital Expenditures stood at -$1.2 million in 2021, then tumbled by 57.39% to -$1.8 million in 2022, then surged by 127.9% to $508000.0 in 2023, then plummeted by 54.53% to $231000.0 in 2024, then crashed by 31.17% to $159000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $159000.0, $90000.0, and $65000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.